Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
To assess the influence of multiple doses of BI 425809 on single dose pharmacokinetics of
midazolam (CYP3A4 probe drug), warfarin (CYP2C9 probe drug), omeprazole (CYP2C19 probe drug)
and digoxin (P-gp probe drug)